Limb girdle muscular dystrophy type 2A in India: A study based on semi-quantitative protein analysis, with clinical and histopathological correlation

Neurology India

Volumn 58, Issue 4, 2010, Pages 549-554

  Pathak, Pankaj ^a,b   Sharma, Mehar C ^a   Sarkar, Chitra ^a   Jha, Prerana ^a   Suri, Vaishali ^a   Mohd, Husain ^b   Singh, Sumit ^a   Bhatia, Rohit ^a   Gulati, Sheffali ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b JAMIA MILLIA ISLAMIA CENTRAL UNIVERSITY   (India)

Author keywords

calpain 3; calpainopathy; immunoblotting; immunohistochemistry; India; LGMD2A; lobulated fibers

Indexed keywords

CALPAIN 3; DYSFERLIN; CALPAIN; CAPN3 PROTEIN, HUMAN; CREATINE KINASE; DYSF PROTEIN, HUMAN; MEMBRANE PROTEIN; MUSCLE PROTEIN;

ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INDIA; LIMB GIRDLE MUSCULAR DYSTROPHY; MALE; MUSCLE BIOPSY; NECROSIS; NERVE REGENERATION; PHENOTYPE; PRESCHOOL CHILD; PROTEIN ANALYSIS; SCHOOL CHILD; ADOLESCENT; BLOOD; ELECTROMYOGRAPHY; GENETICS; METABOLISM; MIDDLE AGED; MUSCLE; MUSCULAR DYSTROPHIES, LIMB-GIRDLE; MUTATION; ONSET AGE; PATHOLOGY; PROCEDURES; STATISTICS; YOUNG ADULT;

ADOLESCENT; ADULT; AGE OF ONSET; CALPAIN; CHILD; CHILD, PRESCHOOL; CREATINE KINASE; ELECTROMYOGRAPHY; FEMALE; HUMANS; INDIA; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MUSCLE PROTEINS; MUSCLES; MUSCULAR DYSTROPHIES, LIMB-GIRDLE; MUTATION; STATISTICS AS TOPIC; YOUNG ADULT;

EID: 77956352761     PISSN: 00283886     EISSN: 19984022     Source Type: Journal    
DOI: 10.4103/0028-3886.68675     Document Type: Article

References (36)

1. Bushby KM. Making sense of the limb-girdle muscular dystrophies. Brain 1999;8:1403-1420
2. Pollitt C, Anderson LV, Pogue R, Davison K, Pyle A, Bushby KM. The phenotype of calpainopathy: diagnosis based on a multidisciplinary approach. Neuromuscul Disord 2001;11:287-296
3. Fardeau M, Hillaire D, Mignard C, Feingold N, Feingold J, Mignard D, et al. Juvenile limb-girdle muscular dystrophy: Clinical, histopathological and genetic data from a small community living in the Reunion Island. Brain 1996;1:295-308.
4. Dincer P, Leturcq F, Richard I, Piccolo F, Yalnizoglu D, de Toma C, et al. A biochemical, genetic, and clinical survey of autosomal recessive limb girdle muscular dystrophies in Turkey. Ann Neurol 1997;42:222-229
5. Topaloglu H, Dincer P, Richard I, Akcoren Z, Alehan D, Ozme S, et al. Calpain-3 deficiency causes a mild muscular dystrophy in childhood. Neuropediatrics 1997;28:212-216
6. Urtasun M, Saenz A, Roudaut C, Poza JJ, Urtizberea JA, Cobo AM, et al. Limb-girdle muscular dystrophy in Guipuzcoa (Basque Country, Spain). Brain 1998;9:1735-1747
7. Angelini C, Fanin M. GeneReviews: Calpainopathy. Gene Reviews 2007;1-16.
8. Sharma MC, Mannan R, Singh NG, Gulati S, Kalra V, Sarkar C. Sarcoglycanopathies: a clinicopathological study of 13 cases. Neurol India 2004;52:446-449
9. Meena AK, Sreenivas D, Sundaram C, Rajshekhar R, Sita JS, Borgohain R, et al. Sarcoglycanopathies: a clinico-pathological study. Neurol India 2007;55:117-121
10. Khadilkar S V, Singh RK, Kulkarni KS, Chitale AR. A study of clinical and laboratory features of 14 Indian patients with dysferlinopathy. J Clin Neuromuscul Dis 2004;6:1-8.
11. Nalini A, Gayathri N. Dysferinopathy: a clinical and histopathological study of 28 patients from India. Neurol India 2008;56:379-387
12. Urtizberea JA. France Lecture, Limb girdle muscular dystrophies: The clinicopathological viewpoint. Ann Indian Acad Neurol 2007;10:214-224
13. Fanin M, Nardetto L, Nascimbeni AC, Tasca E, Spinazzi M, Padoan R, et al. Correlations between clinical severity, genotype and muscle pathology in limb girdle muscular dystrophy type 2A. J Med Genet 2007;44:609-614
14. Talim B, Ognibene A, Mattioli E, Richard I, Anderson LV, Merlini L. Normal calpain expression in genetically confirmed limb-girdle muscular dystrophy type 2A. Neurology 2001;56:692-693
15. De Paula F, Vainzof M, Passos-Bueno MR, de Cássia M Pavanello R, Matioli SR, V B Anderson L,. Clinical variability in calpainopathy: what makes the difference? Eur J Hum Genet 2002;10:825-832
16. Fanin M, Fulizio L, Nascimbeni AC, Spinazzi M, Piluso G, Ventriglia VM, et al. Molecular diagnosis in LGMD2A: mutation analysis or protein testing? Hum Mutat 2004;24:52-62.
17. Fanin M, Nascimbeni AC, Fulizio L, Trevisan C P, Meznaric-Petrusa M, Angelini C, et al. Loss of calpain-3 autocatalytic activity in LGMD2A patients with normal protein expression. Am J Pathol 2003;163:1929-1936
18. Fanin M, Nascimbeni AC, Tasca E, Angelini C. How to tackle the diagnosis of limb-girdle muscular dystrophy. Eur J Hum Genet 2009;17:598-603.
19. Chae J, Minami N, Jin Y, Nakagawa M, Murayama K, Igarashi F, et al. Calpain 3 gene mutations: genetic and clinico-pathologic findings in limb-girdle muscular dystrophy. Neuromuscul Disord 2001;11:547-555
20. Huang Y, Laval SH, van Remoortere A, Baudier J, Benaud C, Anderson LV, et al. AHNAK, a novel component of the dysferlin protein complex, redistributes to the cytoplasm with dysferlin during skeletal muscle regeneration. FASEB J 2007;21:732-734
21. Zatz M, de Paula F, Starling A, Vainzof M. The 10 autosomal recessive limb-girdle muscular dystrophies. Neuromuscul Disord 2003;13:532-544
22. Saenz A, Leturcq F, Cobo AM, Poza JJ, Ferrer X, Otaegui D, et al. LGMD2A: genotype-phenotype correlations based on a large mutational survey on the calpain 3 gene. Brain 2005;128:732-742
23. Groen EJ, Charlton R, Barresi R, Anderson LV, Eagle M, Hudson J, et al. Analysis of the UK diagnostic strategy for limb girdle muscular dystrophy 2A. Brain 2007;12:3237-3249
24. Chou FL, Angelini C, Daentl D, Garcia C, Greco C, Hausmanowa-Petrusewicz I, et al. Calpain III mutation analysis of a heterogeneous limb-girdle muscular dystrophy population. Neurology 1999;52:1015-1020
25. Zatz M, Vainzof M, Passos-Bueno MR. Limb-girdle muscular dystrophy: one gene with different phenotypes, one phenotype with different genes. Curr Opin Neurol 2000;13:511-517
26. Moore SA, Shilling CJ, Westra S, Wall C, Wicklund M P, Stolle C, et al. Limb-girdle muscular dystrophy in the United States. J Neuropathol Exp Neurol 2006;65:995-1003.
27. Van Der Kooi AJ, Frankhuizen WS, Barth PG, Howeler CJ, Padberg G W, Spaans F, et al. Limb-girdle muscular dystrophy in the Netherlands: gene defect identified in half the families. Neurology 2007;68:2125-2128
28. Kawai H, Akaike M, Kunishige M, Inui T, Adachi K, Kimura C, et al. Clinical, pathological, and genetic features of limb-girdle muscular dystrophy type 2A with new calpain 3 gene mutations in seven patients from three Japanese families. Muscle Nerve 1998;21:1493-1501
29. Dincer P, Leturcq F, Richard I, Piccolo F, Yalnizoglu D, de Toma C, et al. A biochemical, genetic, and clinical survey of autosomal recessive limb girdle muscular dystrophies in Turkey. Ann Neurol 1997;42:222-229
30. Urtasun M, Saenz A, Roudaut C, Poza JJ, Urtizberea JA, Cobo AM, et al. Limb-girdle muscular dystrophy in Guipuzcoa (Basque Country, Spain). Brain 1998;9:1735-1747
31. Pogoda T V, Krakhmaleva IN, Lipatova NA, Shakhovskaya NI, Shishkin SS, Limborska SA. High incidence of 550delA mutation of CAPN3 in LGMD2 patients from Russia. Hum Mut 2000;15:295-300.
32. Chae J, Minami N, Jin Y, Nakagawa M, Murayama K, Igarashi F, et al. Calpain 3 gene mutations: genetic and clinico-pathologic findings in limb-girdle muscular dystrophy. Neuromuscul Disord 2001;11:547-555
33. Reich D, Thangaraj K, Patterson N, Price AL, Singh L. Reconstructing Indian population history. Nature 2009;461:489-494
34. Genetic landscape of the people of India: a canvas for disease gene exploration. Indian genome variation consortium. J Genet 2008;87:3-20.
35. Guglieri M, Magri F, D'Angelo MG, Prelle A, Morandi L, Rodolico C, et al. Clinical, molecular, and protein correlations in a large sample of genetically diagnosed Italian limb girdle muscular dystrophy patients. Hum Mutat 2008;29:258-266
36. Fanin M, Pegoraro E, Matsuda-Asada C, Brown RH Jr, Angelini C. Calpain-3 and dysferlin protein screening in patients with limb-girdle dystrophy and myopathy. Neurology 2001;56:660-665